ANGIOMAX

This brand name is authorized in Australia, New Zealand, United States

Active ingredients

The drug ANGIOMAX contains one active pharmaceutical ingredient (API):

1 Bivalirudin UNII TN9BEX005G - BIVALIRUDIN

Bivalirudin is a direct and specific thrombin inhibitor that binds both to the catalytic site and the anion-binding exosite of fluid-phase and clot-bound thrombin. Read about Bivalirudin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ANGIOMAX Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AE06	Bivalirudin	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8844L
Country: CA	Health Products and Food Branch	Identifier(s): 02246533
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 8383, 9424
Country: US	FDA, National Drug Code	Identifier(s): 0781-3447, 65293-001, 70511-141